EUVIMEDEUVIMED entdecken
Kohortenstudie

Effectiveness of 17-OHP for Prevention of Recurrent Preterm Birth: A Retrospective Cohort Study

Joe B Hakim iD, Amy Zhou, Sonia Hernandez-Diaz, Jessica M Hart, Blair J Wylie, Andrew L Beam

American Journal of Perinatology · 01.03.2024 · 41 (04) · 405-413

DOI: 10.1055/s-0041-1740512 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2024. Verfasst von Joe B Hakim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Harvard-MIT, Cambridge, Massachusetts. Hauptthemen laut MEDLINE: Hydroxyprogesterones, Premature Birth. Die Arbeit nennt 25 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

17-α-hydroxyprogesterone caproate (17-OHP) has been recommended by professional societies for the prevention of recurrent preterm birth, but subsequent clinical studies have reported conflicting efficacy results. This study aimed to contribute to the evidence base regarding the effectiveness of 17-OHP in clinical practice using real-world data. Study Design A total of 4,422 individuals meeting inclusion criteria representing recurrent spontaneous preterm birth (sPTB) were identified in a database of insurance claims, and 568 (12.8%) received 17-OHP. Crude and propensity score-matched recurrence rates and risk ratios (RRs) for the association of receiving 17-OHP on recurrent sPTB were calculated.

Results

Raw sPTB recurrence rates were higher among those treated versus not treated; after propensity score matching, no association was detected (26.3 vs. 23.8%, RR = 1.1, 95% CI: 0.9–1.4).

Conclusion

We failed to identify a beneficial effect of 17-OHP for the prevention of spontaneous recurrent preterm birth in our observational, U.S. based cohort. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxyprogesteronesPremature BirthFemaleInfant, NewbornHumansRetrospective StudiesGestational AgeRecurrence

Substanzen

Hydroxyprogesterones

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Harvard-MIT, Cambridge, Massachusetts.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Divisiont of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Joe B Hakim

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Hakim, J. B., Zhou, A., Hernandez-Diaz, S., Hart, J. M., Wylie, B. J., & Beam, A. L. (2024). Effectiveness of 17-OHP for Prevention of Recurrent Preterm Birth: A Retrospective Cohort Study. American Journal of Perinatology, 41(04), 405-413. https://doi.org/10.1055/s-0041-1740512

Vancouver

Hakim JB, Zhou A, Hernandez-Diaz S, Hart JM, Wylie BJ, Beam AL. Effectiveness of 17-OHP for Prevention of Recurrent Preterm Birth: A Retrospective Cohort Study. American Journal of Perinatology. 2024;41(04):405-413. doi:10.1055/s-0041-1740512

BibTeX
@article{Hakim2024,
  author = {Hakim, Joe B and Zhou, Amy and Hernandez-Diaz, Sonia and Hart, Jessica M and Wylie, Blair J and Beam, Andrew L},
  title = {Effectiveness of 17-OHP for Prevention of Recurrent Preterm Birth: A Retrospective Cohort Study},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {04},
  pages = {405--413},
  doi = {10.1055/s-0041-1740512}
}
Kostenlos starten →